That's the Spot!

Autogen separates signal from background on microarray images. Microarray technology is revolutionizing drug discovery, genetic diagnostics, and genomic research. However, processing and analyzing images can be problematic. Semiautomated processing tools such as BioDiscovery's ImaGene™ now enable scientists to process images more efficiently and quickly. Given the array boundaries, this technology locates each spot, and graphic user interface tools facilitate manual correction of misidenti

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Autogen separates signal from background on microarray images.
Microarray technology is revolutionizing drug discovery, genetic diagnostics, and genomic research. However, processing and analyzing images can be problematic. Semiautomated processing tools such as BioDiscovery's ImaGene now enable scientists to process images more efficiently and quickly. Given the array boundaries, this technology locates each spot, and graphic user interface tools facilitate manual correction of misidentified spots.

Although semiautomated processing software provides clear advantages over previous microarray image analysis methods, its accuracy depends on the user's knowledge and experience. A fully automated system would provide consistency and minimize the possibility of human error. To this end, BioDiscovery has recently introduced the AutoGene Microarray Image Analysis System, a fully automated system that searches an image for DNA hybridization spots without any human assistance. AutoGene, which works with both membranes and slides, detects and separates spot signals from contamination and background. The operator just inputs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies